DNA-dependent protein kinase catalytic subunit (DNA-PK) is a pleiotropic kinase involved in DNA repair and transcriptional regulation. DNA-PK is deregulated in selected cancer types and is strongly associated with poor outcome.
Elevated levels of DNA-PK have been observed in various cancers, including breast cancer, lung cancer, and liver cancer. High expression levels are often associated with aggressive tumor characteristics and poor prognosis.
Conversely, low expression of DNA-PK may be linked to increased sensitivity to certain therapies, particularly those that induce DNA damage, such as radiation and some chemotherapeutic agents.
(Will delete Record if Target field = "Delete") Home